Clinical Trials Browser

INDUSTRY × Has results × BMS-833923 × Clear all

NCT01357655 2017-03-14

Phase 2 Dasatinib Combo With Smoothened (SMO) Antagonist (BMS-833923)

Phase 2 Terminated

70 enrolled 8 charts

Other hematologic neoplasm

Bronchiolitis Obliterans Syndrome, Leukemia

NCT01218477 2016-06-17

Dasatinib Combination Therapy With the Smoothened (SMO) Inhibitor BMS-833923 in Chronic Myeloid Leukemia (CML)

Phase 1/2 Completed

33 enrolled 18 charts

Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Chronic-Phase